Filing Flows › Adtran Holdings (ADTN) › R&D spending
Adtran Holdings (ADTN) R&D spending by quarter
Adtran Holdings' R&D spending was $52.0M in Q3 2026 (third quarter 2026), -3% from Q2 2026. Over the last 7 quarters it ranged from $48.9M (Q1 2025) to $53.8M (Q2 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $52.0M | -3% | +0.6% |
| Q2 2026 | $53.8M | +6% | +4% |
| Q1 2026 | $50.8M | -2% | +4% |
| Q4 2025 | $51.8M | +0.3% | — |
| Q3 2025 | $51.7M | -0.4% | — |
| Q2 2025 | $51.9M | +6% | — |
| Q1 2025 | $48.9M | — | — |
Q3 2026 at a glance
Adtran Holdings, Q3 2026: revenue $281M (+0.6% year over year), operating margin -0.3%, net loss $7.1M, operating cash flow −$24.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is Adtran Holdings' R&D spending?
Adtran Holdings' R&D spending was $52.0M in Q3 2026 (third quarter 2026), -3% from Q2 2026.
How has Adtran Holdings' R&D spending changed?
Over the last 7 quarters it ranged from $48.9M (Q1 2025) to $53.8M (Q2 2026).